Kongsberg Gruppen ASA (KBGGY)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,065	19,819	8,073	7,451	5,719	3,696
Market Cap Growth	136.90%	145.49%	8.35%	30.29%	54.73%	30.83%
Enterprise Value	25,244	19,658	8,528	7,693	5,543	3,409
Last Close Price	14.84	11.17	4.25	-	-	-
PE Ratio	39.28	43.93	22.05	26.47	23.34	10.96
PS Ratio	4.96	4.61	2.02	2.31	1.84	1.24
PB Ratio	13.88	11.69	4.97	5.34	3.70	2.38
P/TBV Ratio	21.99	15.94	7.22	8.14	5.30	3.50
P/FCF Ratio	23.48	18.75	21.18	163.13	11.44	14.56
P/OCF Ratio	20.34	16.38	14.05	66.37	10.14	11.52
EV/Sales Ratio	4.88	4.57	2.13	2.38	1.78	1.14
EV/EBITDA Ratio	28.97	30.78	16.30	19.02	13.72	10.65
EV/EBIT Ratio	33.91	34.21	18.63	22.75	16.99	14.47
EV/FCF Ratio	22.74	18.60	22.38	168.43	11.08	13.43
Debt / Equity Ratio	0.28	0.24	0.30	0.32	0.32	0.42
Debt / EBITDA Ratio	0.62	0.61	0.84	0.99	1.09	1.76
Debt / FCF Ratio	0.47	0.39	1.26	9.77	0.98	2.56
Asset Turnover	0.83	0.80	0.84	0.77	0.70	0.66
Inventory Turnover	2.96	2.51	2.49	2.29	2.27	2.19
Quick Ratio	0.86	0.91	0.85	0.82	1.03	0.98
Current Ratio	1.06	1.13	1.14	1.12	1.29	1.24
Return on Equity (ROE)	38.20%	28.79%	24.60%	20.54%	17.01%	11.34%
Return on Assets (ROA)	7.05%	6.65%	6.02%	5.04%	4.57%	3.23%
Return on Capital (ROIC)	19.95%	18.01%	14.69%	11.54%	9.76%	6.65%
Return on Capital Employed (ROCE)	29.50%	25.40%	20.60%	17.40%	14.30%	10.30%
Earnings Yield	2.55%	2.28%	4.53%	3.78%	4.29%	9.13%
FCF Yield	4.26%	5.33%	4.72%	0.61%	8.74%	6.87%
Dividend Yield	0.68%	1.58%	3.25%	-	-	-
Payout Ratio	45.22%	48.05%	17.19%	98.67%	66.70%	15.57%
Buyback Yield / Dilution	-0.05%	0.10%	0.73%	0.92%	0.43%	0.09%
Total Shareholder Return	0.63%	1.67%	3.98%	0.92%	0.43%	0.09%

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.